CNA Financial Corporation CNA
Composite 55/100; the shares have moved about 24% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Quality ranks 30/100 — a moderate mark against it.
Valuation ranks 93/100 — a strong point in its favour. Income ranks 78/100 — a strong point in its favour. Growth ranks 61/100 — a slight point in its favour.
Quality ranks 30/100 — a moderate mark against it. Balance-sheet strength ranks 37/100 — a moderate mark against it.
What the company does CNA Financial provides commercial property and casualty insurance across the U.S., Canada, U.K., and Europe through segments like Specialty, Commercial, and Life & Group. It offers liability, workers’ compensation, cyber, and surety products to small and mid-size firms, healthcare providers, and public entities.
Key financials ROE 11.5%, ROA 1.5%, ROCE 5.6%; gross/operating/net margins 30.6%/7.5%/7.9%. Revenue growth 10.0%, EPS growth -22.2%. Debt/Equity 0.27, interest coverage 12.31, current ratio 0.36. Dividend yield 3.6%, payout 41.6%.
Stock health Sideravia scores: Quality 43.1, Growth 34.0, Strength 44.6, Valuation 87.7, Momentum 70.8, Income 89.8. Piotroski F-Score 8/9, Altman Z 0.21. 12-month momentum 36.21%, RSI(14) 73.10.
Price vs fair value CNA trades at a discount of 29.80% to our fair-value estimate of 71.61 and at a PREMIUM of 18.42% to the analyst 12-month target of 45.00. - Simply Wall St flags the 28% fair-value gap as “reasonable” (Simply Wall St) - Zacks projects Q2 EPS decline, weighing on near-term sentiment (Zacks) - StockStory highlights CNA as “unpopular” relative to peers (StockStory) - Arch Capital’s earnings beat may reinforce competitive pressure (Zacks)
Looking forward Forward P/E 10.35 and PEG 0.65 suggest valuation support, but weak growth (34.0) and elevated RSI warrant caution. Dividend yield 3.6% and FCF yield 12.2% provide income and cash backing.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.